Clinical trial · Interventional
Comparison Between Different Ways for Using Lidocaine During FB
Comparison Between Nebulized Lidocaine, Lidocaine Spray, or Their Combination for Topical Anesthesia During Diagnostic Flexible Bronchoscopy: a Randomized Trial
NCT06563050CI-TRIAL-00080055not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
compare the efficacy and safety of nebulized lidocaine, oropharyngeal lidocaine spray, or their combination for better outcome of topical anesthesia in subjects undergoing diagnostic FB; severity of cough , pain during procedure , cumulative dose of anesthesia needed and its adverse reaction , overall satisfaction .
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lidocaine Spray | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Lung Diseases | — | UNRESOLVED | — |
| Nebulized Lidocaine | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Combination of nebulized lidocaine and lidocaine spray | Procedure | — | UNRESOLVED |
| Lidocaine spray | Procedure | — | UNRESOLVED |
| Nebulized lidocaine | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Nebulized lidocaine
- description
- Subjects in group A underwent nebulization with 5 mL of 2% lidocaine for 15 minutes by using a jet nebulizer.
- interventionNames
- Procedure: Nebulized lidocaine
- type
- EXPERIMENTAL
- label
- Lidocaine spray
- description
- In group B will underwent 10% lidocaine spray solution will be sprayed 10 times at the oropharynx at 5 s interval.
- interventionNames
- Procedure: Lidocaine spray
- type
- EXPERIMENTAL
- label
- Combination( Nebulized lidocaine and lidocaine spray)
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients above 18 years old will undergo FB are included in this study. Exclusion Criteria: * known hypersensitivity to lidocaine. * Pregnancy. * hemodynamic instability. * failure to provide informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.